Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019

 
Table of Contents
I. Report Focus
 
 I. Introduction
 
 A. Regenerative Medicine Р In Brief
 History Of Organ Engineering
 
 The Methodology Of Regenerative Medicine
 1) Human Substances
 2) Cells And Tissues 
 3) Embryonic Stem Cells
 Nuclear Transplantation
 Opposition To Use Of Embryonic Stem Cells And Nuclear Transplantation
 
 4) Novel Materials
 The Competent Association Between Regenerative Medication And Physical Therapeutics
 Clinical Tools And Synthetic Organs
 Material Treatments And Bio Substances
 Cellular Treatments
 Prevalent Hurdles In The Progress Of Cellular Therapies
 Barriers
 Skeletal Muscle
 Cardiac
 Bone
 Objective Measures Toward Regenerative Rehabilitation
 Conclusions
 
 B. Tissue Engineering
 Regenerative Medicine And Tissue Engineering
 History Of Tissue Engineering
 Methods Of Tissue Engineering
 Tissue Engineering And Regenerative Medicine In The Current Medical Order 
 Nih Sponsored Research In Tissue Engineering And Regenerative Medicine 
 Influencing Stem Cells By Manipulating Their Environment
 Transplanting Human Livers In Mice
 Engineering Mature Bone Stem Cells
 Using Lattices To Help Engineered Tissue Survive
 Possible Treatment Option For Worn Out/Injured Knees
 Re-Growing A New Kidney 
 
 Tissue Engineering And Biomaterials
 Cell And Tissue Banking Standards And Accreditation
 
 C. Stem Cells
 Introduction To Stem Cells
 History Of Stem Cells
 
 Types Of Stem Cells
 1) Embryonic Stem (Es) Cells And Epiblast Stem Cells
 2) Non-Embryonic Stem Cells (Non-Esc)
 Tissue Stem Cells
 Induced Pluripotent Stem (Ips) Cells 
 
 Regenerative Medicine And Stem Cells 
 The Microenvironment Of The Stem Cell 
 Embryonic Stem Cells A More Detailed Look
 Blastocyst As A Source Of Stem Cells Legal Issues 
 Non-Embryonic Stem Cells
 1) Amniotic Fluid Derived Stem Cells 
 2) Cord Blood Stem Cells
 Type-1 Diabetes
 Cardiovascular Conditions
 Central Nervous System 
 
 3) Bone-Marrow Derived Stromal Stem Cells 
 4) In-Vitro Msc Differentiation
 5) Stem Cells Derived From Fat Tissue
 6) Monocytes
 
 Stem Cell Treatments Why Havenхt They Gained Widespread Popularity?
 
 Applications Of Stem Cells In Treatment Of Various Diseases And Conditions
 
 A) Bone 
 I) Bone Defects
 Ii) Fracture Non-Union
 Iii) Osteogenesis Imperfecta
 
 B) Cartilage
 
 C) Cardiac Muscle
 
 D) Urinary Tissues Р Bladder
 
 E) Spinal Cord
 
 Conclusion
 
 Cell-Based Therapies
 Cells Developed Today Are Future Therapies
 
 D. Biological Substitutes For Regenerative Medicine
 Areas In Human Tissue Construction
 Biomaterials
 Cells
 Biomolecules 
 Safety And Presentation Concerns
 Developmental Features 
 Other Factors
 
 E. Regenerative Medicine And Various Conditions
 1. Skin/ Integumentary
 Skin-Treatment
 Skin Revival
 Nerve Revival
 Skeletal Muscle Revival
 
 Regenerative Drugs For Skin Diseases Ips Cells To The Salvage
 
 Skin And Cutaneous Cells And Tissue Applications Opt For Development
 
 Do-Us Association In Regenerative Medicine To Support Acid Attack Victims
 
 2. Regenerative Medicineхs Progress In Orthopedics
 Contemporary Notions
 Approaches 
 Cells
 Morphogenetic Stimulus
 Scaffolds
 Mechanical Stimulation
 Advancement
 Bone
 
 Regenerative Medicine In The Bone
 Cartilage
 Other Organs
 A. Intervertebral Disk
 B. Meniscus
 C. Ligament And Tendon
 
 Gene Therapy Strategy
 
 Gene Therapy Commercial Milestones
 2013
 2012
 2010
 
 Viewpoints
 
 3. Cardiac Regenerative Medicine
 Cardiovascular And Regenerative Medicine
 Outline
 Type Of Cvd
 
 Cardiovascular Disease And Revival Medicine
 Aastrom
 Amorcyte
 Athersys Inc.Хs
 Capricor 
 Cytomedix
 Cytori Therapeutics
 Juventas Therapeutics
 Mesoblastхs
 
 4. Regenerative Drugs For Neurological Disabilities
 Regenerative Drugs For Neurological Diseases With The Use Of Electrical Stimulation
 1. Introduction
 2. Electrical Stimulus For Cerebral Infarction
 3. Long-Term Potentiation And Neurogenesis
 Conclusion
 
 5. Regenerative Nephrology
 Regenerative Drug Strategies To Heal Neurogenic Bladder
 Introduction
 
 6. The Essentials Of Tissue Engineering
 Bio-Substances Used In Genitourinary Tissue Renovation
 Cells For Urogenital Tissue Regeneration Technologies
 Tissue Programming Strategies For Bladder Boost And Replacement
 Biosubstances Scaffolds For Bladder Regeneration
 Regenerative Drugs For Bladder Using Cell Transplantation
 Conclusion
 
 7. Diabetes And Regenerative Medicine
 
 8. Alzheimer's And Regenerative Medicine
 
 9. Autoimmune Disorders And Regenerative Medicine
 
 10. Regenerative Medicine In Ophthalmology - Prospect
 Preamble
 Cellular Treatments
 Results - Advantages
 Limitations
 
 Bio-Substances In The Cornea
 Corneal Replacements Are A Possible Option That Needs To Address
 Bio-Substances Need To Be 
 Overview Of Kpro
 
 Exercise Engineering Structure To Corneal Disease
 
 F. Regenerative Medicine The Future Trends
 Altered Demographics Create Greater Burden Of Chronic Disease
 An Emerging Industry
 Obtaining Regulatory Norms In Place
 Fda Procedures
 Cross-Agency Management
 Regulatory Discipline
 
 G. Government Funding
 Public And Private Investment Exceeds $1 Billion
 
 H. Us Healthcare Statistics
 The Cost Impact Of An Aging Population
 Potential Economic Impact Of Regenerative Medicine
 
 Ii. Regenerative Medicine - Market Briefing
 The Americas
 Europe
 Asia-Pacific
 Rest Of World
 
 Ii. Market Analysis
 Regenerative Medicine Р Industry Snapshot
 
 A. Regenerative Medicine - Segmentation
 
 Regenerative Medicine Р Global
 Regenerative Medicine - By Geography
 The Americas
 Europe
 Asia-Pacific
 Rest Of World
 
 Regenerative Medicine - By Therapeutic Area
 Regenerative Medicine - Therapeutic Area - By Geography
 Orthopedics
 The Americas
 Europe
 Asia-Pacific
 Rest Of World
 
 Skin/Integumentary
 The Americas
 Europe
 Asia-Pacific
 Rest Of World
 
 Cardiology
 The Americas
 Europe
 Asia-Pacific
 Rest Of World
 
 Neurology
 The Americas
 Europe
 Asia-Pacific
 Rest Of World
 
 Urology
 The Americas
 Europe
 Asia-Pacific
 Rest Of World
 
 Other Therapeutic Areas (Regenerative Medicine)
 The Americas
 Europe
 Asia-Pacific
 Rest Of World
 
 Regenerative Medicine - Biological Substitutes - By Type
 
 B. Growth Rate Analysis
 A. Regenerative Medicine Market Growth Rates Р By Geography
 B. Regenerative Medicine Market Р By Therapeutic Area Growth Rates
 
 C. Investment Focus
 
 Iii. Industry Overview
 A. Industry Activities
 Mergers/Acquisitions/Agreements/Patents Grants/Joint Ventures/Trends, Etc
 Kite Pharma Establishes Manufacturing Capabilities To Support Development And Commercialization Of Car And Tcr Cancer Immunotherapy Products
 Significant Findings In U.S. National Institutes Of Healthхs Trial Of Pluristemхs Plx-R18 Cells For Treatment Of Acute Radiation Syndrome
 Novasep Selected To Commercially Biomanufacture Celladonхs Mydicar Api
 Cytori Begins Enrollment In Act-Oa: Us Phase Ii Trial For Knee Osteoarthritis
 Can 3-D Printing Of Living Tissue Speed Up Drug Development?
 Team Creates New Approach To Gene Therapy
 Cellular Dynamics' Icell Hepatocytes Enable Malaria-In-A-Dish Studies
 Cesca Therapeutics Announces Approval Of Its Marrowxpresstm System In India
 Voyager Therapeutics & Genzyme Announce Major Strategic Collaboration To Develop And Commercialize Novel Aav Gene Therapies For Patients With Cns Disorders 
 Valeant Pharmaceuticals Announces Expiration Of Bid Deadline In Connection With Agreement To Acquire Assets From Dendreon
 3-D Printers Take Center Stage In Japanхs Regenerative Medicine
 Cynata Partners With Uwa Centre For Cell Therapy And Regenerative Medicine
 Astrazeneca Announces Collaborations To Use Crispr Technology For Genome Editing Across Its Drug Discovery Platform
 Avita Medical Announces First Patient Enrolment In Us Pivotal Study Of Recell 
 Using 3d Printing, Makerbot And Feinstein Institute For Medical Research Create Cartilage To Repair Tracheal Damage
 Sistemic And Roslin Cells Announce Ground-Breaking Collaboration Agreement On Ipsc Characterisation As Part Of Major European Innovative Medicines Initiative Programme
 Athersys And Cell Therapy Catapult Announce Grant To Support Clinical Development Of Stem Cell Therapy For Severe Acute Respiratory Condition
 Cell Therapy Catapult And Trakcel To Collaborate On Research Project
 Neostem And Invetech Announce Agreement To Develop Closed Processing System For Cell Therapy Manufacturing
 Nuo Therapeutics And Rohto Pharmaceutical Co. Sign Exclusive Licensing And Distribution Agreement For Aurix In Japan
 Researchers Grow Functional Tissue-Engineered Intestine From Human Cells
 Hart And Mayo Clinic Collaborate On Regenerated Trachea, Esophagus And Heart Valve
 Novartis Collaborates With Intellia Therapeutics And Caribou Biosciences To Explore Making Medicines And Drug Discovery Tools With Crispr Genome Editing Technology
 Txcell And Ferring Collaboration With Lead Product Ovasave
 Orthocell And Bonesupport Enter Into Bone Repair Partnership
 Invivo Therapeutics Announces Fda Approval To Expedite Enrollment For Ongoing Pilot Trial
 Biotime, Inc. Subsidiary Oncocyte Corporation Completes Initial Enrollment Of Clinical Study Of Urine-Based Bladder Cancer Diagnostic
 Heraeus Medical Licenses Platform Polymer Technology To Further Its Regenerative Orthopedics Strategy
 Voyager Therapeutics And Massbiologics Announce Strategic Collaboration For Viral Vector Manufacturing
 Nyscf And The Cmta Enter Collaboration To Advance Neuropathies Research
 Leading Bone Repair Company Bonesupport And Regenerative Medicine Company Orthocell Ltd Announce A Heads Of Agreement
 Pfizer Expands Rare Disease Research With Establishment Of Gene Therapy Platform
 Establishment Of Gene Therapy Research In Pfizer Rare Disease
 Ge Healthcare Life Sciences Licenses Crispr Gene Engineering Technology Patents From Broad Institute
 Organovo Collaborates With Yale Team To Develop 3-D Organ Tissues For Surgical Transplantation Research
 Pluristem Granted Patent In Singapore For Its 3d Cell Expansion Technology
 Stem Cell Agency & Israel Announce International Collaboration To Advance Stem Cell Research
 Harvard Apparatus Regenerative Technology No Longer Supporting Studies In Russia; Will Continue Focus On Preclinical Processes In The U.S. And Eu
 Japanese Legislation Takes Effect For Expedited Approvals Of Regenerative Medical Products
 Aastrom Biosciences Changes Name To Vericel Corporation
 Juno T Cell Therapy For Leukemia Granted Fda Breakthrough Therapy Designation
 Ocata Therapeutics Receives Advanced Therapy Medicinal Product Designation From The European Medicines Agency
 Transposagen Biopharmaceuticals Enters Into Research Collaboration And Worldwide License Agreement With Janssen For Allogeneic Chimeric Antigen Receptor (Car) T-Cell Therapies
 Poland And California Announce International Collaboration To Advance Stem Cell Research Toward Cures
 Advanced Cell Technology Changes Name To Ocata Therapeutics
 Cytomedix Announces Corporate Name Change To Nuo Therapeutics, Inc.
 Cardio3 Biosciences Acquires Corquest Medical Inc.
 University And Gsk Collaboration Aims To Tackle Myelin Regeneration
 The New York Stem Cell Foundation Research Institute Announces Largest-Ever Stem Cell Repository
 Terumo Bct And Oneblood Partner In A Treatment Use Program Of An Investigational Device To Help Improve Blood Supply Safety
 Roosterbio Selects Biolife Solutions Cryostor To Commercialize Human Bone Marrow-Derived Stem Cells
 Pluristem Advances Its Second Major Cell Therapy Product Line From Development To Large-Scale Manufacturing
 Cytori Patents Automated Tissue Processing Device In Japan And Treatments For Wound Healing In China
 Osiris And Arthrex Announce An Exclusive Partnership For The Commercialization And Development Of Cartiform
 Thermo Fisher Scientific Announces Its Ion Pgm Dx Next Generation Sequencing System Is Now Ce-Marked For In Vitro Diagnostic (Ivd) Use
 Act Announces Positive Results From Two Clinical Trials Published In The Lancet Using Differentiated Stem Cell-Derived Retinal Pigment Epithelium (Rpe) Cells For The Treatment Of Macular Degeneration
 Promethera Biosciences Receives Approval In Belgium To Enroll Patients In The Imminent Hep002 Phase Iib/Iii Clinical Trial
 The National Stem Cell Foundation Partners With The Orthopaedic Research And Education Foundation On Stem Cell Research For The Regeneration And Repair Of Musculoskeletal Tissues
 Cardio3 Biosciences Receives Authorization To Enroll Patients In Switzerland In Its Phase Iii Clinical Trial Chart-1
 Smith & Nephew Announces Top-Line Results Of Hp802-247 Phase 3 Study
 Neostem Ranked As One Of The Fastest Growing Companies In New York City
 Cesca Therapeutics Announces Agreement With New York Upstate Cord Blood Bank
 Oxford Biomedica Acquires Windrush Court Office And Laboratory Facilities
 Astellas Announces Research Collaboration With Harvard Medical School Investigator For Treatment Of Retinal Degeneration
 Oxford Biomedica Announces New Process Development And Manufacturing Collaboration Which Includes Lentivector Licence Agreement
 Bone Therapeutics Extends Allob Phase I/Iia Trial To Germany
 Brainstorm Gets Fda Fast-Track Status For Als Stem Cell Therapy
 Tc Biopharm And Sistemic Announce Collaboration To Develop An Innovative Range Of Cancer-Specific Theranostic Products
 Histogenics And Intrexon Announce Formation Of Exclusive Channel Collaboration For Cartilage Repair Therapies
 Researchers Develop Novel Gene/Cell Therapy Approach For Lung Disease
 Mesoblast Partner Jcr Pharmaceuticals Files For?Marketing Approval Of The First Allogeneic Stem Cell Product In Japan
 Cesca Therapeutics Announces Approval Of Its Axp(R) Autoxpress(R) System In Taiwan
 Horizon Discovery Group Plc Acquires Sage Labs Inc
 Baxter To Form New Global Innovation And R&D Center Near Boston For Its Biopharmaceuticals Business
 Advanced Cell Technology Announces Final Patient Treated In Stargardtхs Macular Degeneration Phase 1 Trial In The United Kingdom
 Fibrocell Science And Intrexon Advance Gm-Hdf-Col7 Toward Clinical Development For The Treatment Of Recessive Dystrophic Epidermolysis Bullosa
 Genzyme Collaborates On Gene Therapy For Rare Disease That Causes Childhood Blindness
 Study Determines Mimedx Allograft Effectively Recruits Circulating Stem And Progenitor Cells
 Biolife Solutions And Savsu Technologies Announce Exclusive Distribution Agreement
 Utsw Researchers Working To Regenerate Heart, Nerve Cells
 Mayo Clinic Center For Regenerative Medicine Forms Collaboration With National University Ireland Galway
 Accurexa Announces Exclusive License Agreement With Uc San Francisco
 Medpace Continues To Expand Therapeutic Leadership In Oncology Drug Development
 Regenerative Medicine To Be Insured
 Mimedx Signs Distribution Agreement With Zimmer
 Cancer Research Uk, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer
 Mabvax Therapeutics Enters Agreements With Memorial Sloan Kettering Cancer Center And Juno Therapeutics For Development Of Anti-Cancer Therapeutics
 Sangamo Biosciences Announces Target Date For First Ind For Sangamoхs In Vivo Zfn Genome-Editing Platform For Monogenic Diseases
 Stem Cell Agency Invests $16 Million To Fight Diabetes And Announces Plan To Launch Cirm 2.0
 Harvard Apparatus Regenerative Technology Obtains Orphan Drug Designation From U.S. Food And Drug Administration For Hart-Trachea
 Scientists Find Way To Expand Blood Stem Cell Production In Lab
 Abbvie And Calico Announce A Novel Collaboration To Accelerate The Discovery, Development, And Commercialization Of New Therapies
 Artificial Virus Promises Effective Drug Delivery And Gene Therapy
 Cellular Biomedicine Group Launches Clinical Research Study For Cartilage Defect Stem Cell Therapy
 Bone Therapeutics Supports Pioneering Research By Backing Projects Vital To Regenerative Medicine Research
 Regeneus's Hiqcell Obtains Approval From Afl
 Biotime To Collaborate With The University Of Wisconsin And Louvain University In Test Of Hystem-Based Hydrogel For Vocal Fold Scarring
 Paving The Way For Gene Therapy In Huntington's Disease
 Asterias Biotherapeutics Receives U.S. Fda Clearance To Initiate Phase 1/2a Clinical Trial Of Ast-Opc1 In Patients With Cervical Complete Spinal Cord Injury
 Cesca Therapeutics Advocates Benefits Of Cell Therapy To The Centers For Medicare And Medicaid Services
 Mesoblast Unveils Path To Bring Its Key Products To Market
 Regeneus Enters Partnership With Cryosite For New Stem Cell Products
 Biolife Solutions Cryostor And Hypothermosol Now Embedded In 130 Regenerative Medicine Clinical Trials
 Viacyte, Inc. Announces Signing Of Rights Agreement With Janssen Research & Development Llc.
 Cytomedix Partners With Net Health To Expand Ced Data Collection Capabilities To Approximately 400 Additional Wound Care Centers
 Novartis To Invest In Israel's Gamida Cell, Could Buy Out Company
 Barda Executes Contract Option With Cytori For Continued Development Of Thermal Burn Injury Counter Measure
 Viacyte, Inc. Announces Fda Acceptance Of Ind To Commence Clinical Trial Of Vc-01 Candidate Cell Replacement Therapy For Type 1 Diabetes
 Fda Clears Mayo Clinic For Manufacture Of Nurown And Participation In Brainstormхs Phase 2 Als Trial
 Engineering New Bone Growth
 The Alliance For Regenerative Medicine And The Alliance For Advanced Therapies Merge
 Tissue Development 'Roadmap' Created To Guide Stem Cell Medicine
 Organovo To Offer Preclinical Drug Tests Based On 3-D Liver Tissue
 Cedars-Sinai Heart Institute Opens First-Of-Its-Kind Research Stem Cell Clinic For Cardiac Patients
 3-D Bioengineered Brain Tissue Grown In Lab
 Stem Cell Therapy: Fda Regulatory Science Aims To Facilitate Development Of Safe And Effective Regenerative Medicine Products
 Uniqure Acquires Cardiology Gene Therapy Company Inocard
 Human Longevity, Inc. And Celgene Cellular Therapeutics Sign License Agreement To Develop And Commercialize Placental Stem Cell Population, Psc-100 For Multiple Therapeutic Applications
 Vivex Biomedical And Akron Biotech: Collaborative Venture In Regenerative Medicine
 Japan's Reprocell Announces Acquisition Of Two Stem Cell Companies
 Chiesi And Uniqure Provide Update On Glybera Launch
 Biolife Solutions Cryostor Demonstrates Superior Cell Preservation In Multicenter Biobanking Study
 Cellular Biomedicine Group Announces Acquisition Of Immune Cell Therapy Technology And U.S. Patent
 Biolife Solutions Cryostor Demonstrates Superior Cell Preservation In Multicenter Biobanking Study
 Light-Induced Nanocarriers Switch On Improved Gene Therapy
 Orthocell Delivers Excellent Results In Tennis Elbow Trial
 Mesoblast Mpcs Trial To Test For End-Stage Heart Failure
 Biotime, Inc. Subsidiary Oncocyte Corporation Expands Clinical Development Of Bladder Cancer Diagnostic By Initiating A Large Multi-Site Clinical Trial
 Carnegie Mellon Chemists Create Nanofibers Using Unprecedented New Method
 Cellectis Sells Its Swedish Subsidiary, Cellectis Ab, To The Japanese Company Takara Bio Inc.
 Wyss Institute Launches Organs-On-Chips-Focused Startup
 Stem Cell Advance May Increase Efficiency Of Tissue Regeneration
 Lion Biotechnologies Announces Exclusive License Agreement With Moffitt Cancer Center
 Whitehead Institute Researchers Create Тna?Veу Pluripotent Human Embryonic Stem Cells
 3-D Printed Tissues Advance Stem Cell Research
 Ziopharm Announces Expansion Of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon And Clinical Program Update
 Lilly And Immunocore Enter Immunotherapy Agreement To Co-Discover And Co-Develop Novel Cancer Therapies
 Transplanting Gene Into Injured Hearts Creates Biological Pacemakers
 Stem Cell Therapy In Cardiovascular Disease: Past Obstacles And Promising New Directions
 Microbiologics Licenses Biomatrica Technology For Molecular Controls
 Regeneus Secures Exclusive Worldwide Rights For New Therapeutic Human Cancer Vaccine
 University Of Pennsylvania's Personalized Cellular Therapy For Leukemia Receives Fda's Breakthrough Therapy Designation
 Researchers Regrow Human Corneas: First Known Tissue Grown From A Human Stem Cell
 Stem Cells: Hope On The Line
 Improving Stem Cells' Regenerative Potential
 Ethics Of Bioengineering Organs And Tissues
 Mesoblast Mpcs Show Encouraging Results In Treating Heart Failure
 Bluebird Bio Acquires Precision Genome Engineering, A Privately Held Gene-Editing Company
 Regeneus Enters Into Us Marketing Trial Agreement For Novel Canine Cancer Vaccine
 Agtc And Safc Create Strategic Partnership To Provide Gene Therapy Manufacturing Services
 Dimension Therapeutics And Bayer Healthcare Enter Collaboration To Develop Novel Gene Therapy For Hemophilia A
 Ut Southwestern Researchers Discover Biomarker For Mesenchymal Stromal Cell Function In Human Body
 Pfizer And Cellectis Enter Into Global Strategic Cancer Immunotherapy Collaboration
 Fibrocell Science Announces Exclusive Technology License Agreements With Ucla To Advance The Development Of Personalized Cell Therapies
 Aastrom Announces Strategic Plan For Recently Acquired Cell Therapy And Regenerative Medicine Business
 Ccrm And Stem Cells Australia Agree To Collaborate In The Global Translation Of Stem Cell Research
 Cardio3 Biosciences Teams Up With Medisun International To Create Cardio3 Biosciences Asia Holdings Ltd, A Joint Venture Aimed At Conducting Pivotal Clinical Programs In Greater China
 Txcell Granted Certificate Of Gmp Compliance From Ansm For Cell Therapy Manufacturing Facility
 Uclb Signs Exclusive Licencing Agreement With Collagen Solutions For Next Generation Collagen Products
 Cellectis Enters Into An Agreement With Cellforcure For The Cgmp Manufacturing Of Allogeneic Cart Cells
 Adaptimmune Enters Strategic Cancer Immunotherapy Collaboration With Glaxosmithkline To Develop And Commercialise Novel Cell-Based Therapies
 Aastrom Completes Acquisition Of Sanofi's Cell Therapy And Regenerative Medicine Business
 Pharmacell To Finalize Purchase Of Cell Therapy Production Facility
 Mesoblast's Mpcs Enhance Outcomes In Type 2 Diabetes
 Ortho-Ati Delivers Promising Results In Treating Hip Tendon Pain
 Stem Cell Agency Invests $32 Million Toward Therapies For Spinal Cord Injury And Hiv/Aids
 Sangamo Biosciences Announces Publication Of Preclinical Data Demonstrating Gene Correction In Scid-X1 Human Hematopoietic Stem Cells
 Device Produces Packaged Batches Of Stem Cells For Regenerative Medicine
 Biorestorative Therapies Signs Research Agreement With Pfizer Inc.
 Roslin Cells Announces New Cell Therapy Manufacturing Contract With Pfizer Inc.
 Pluristem Receives Clearance From South Korea To Use Plx Cells Manufactured At Its New Facility In Its Advances Studies
 Neostem Announces Licensing Agreement And Plans To Begin Phase 2 Hepatocellular Carcinoma Trial In China
 Patient Stem Cells Used To Make Фheart Disease-On-A-Chipх
 Novel Method Grows Cord Blood Cells For Medical Applications
 Regeneron And Avalanche Biotechnologies Announce Collaboration To Develop Next-Generation Gene Therapy Products In Ophthalmology
 Mesoblast Seeks Fda Fast-Track For Gvhd Treatment
 New Hope In Regenerative Medicine
 Regenx Biosciences Enters Into License Agreement With Aavlife For Development Of Treatments For Friedreich's Ataxia Using Nav Vectors
 Avita Medical Launches Enhanced Recell Spray-On Skin Version
 Bristol-Myers Squibb Acquires Ipierian, Inc.
 Md Anderson Announces Immunotherapy Collaboration With Gsk
 Neostem Announces Definitive Agreement To Acquire California Stem Cell, Inc
 Akron Biotech Awarded Sbir Grant For Development Of Novel Method To Isolate Adipose Derived Stem Cells
 Md Anderson Announces Immunotherapy Collaboration With Gsk
 Recell Containing Ambient-Stored Enzyme Launched In United Kingdom And Europe
 Baxter To Acquire Chatham Therapeutics
 Regenx Biosciences And Avexis Enter Into Exclusive Agreement For Development Of Treatments For Sma
 Astellas: Establishment Of Regenerative Medicine Unit
 Companies Collaborate To Advance Dominant Rp Gene Therapy
 Bioheart Announces Clinical Study For Degenerative Disc Disease
 Gene Therapy's Big Comeback
 Survey Of Pharma And Large-Cap Biotech Shows Significant Investment In Regenerative Medicine
 Spark Therapeutics And Genable Technologies Announce Collaboration To Advance A Gene Therapy Treatment For A Rare Form Of Retinitis Pigmentosa
 Brainstorm And Massachusetts General Hospital Sign Definitive Agreement For Als Clinical Trial
 Brainstorm Granted Key Us Patent For Its Autologous Stem Cell Technology
 Medinet Builds Strategic Partnership With Tc Biopharm For The Development And Sales Of A Immuno-Cell Medicinal Product In Europe
 Takeda, Ucl Partner In $250k Study Of Treating Md With Ips Cells
 Histogen Aesthetics Acquires Cellceuticals Biomedical Skin Treatments
 Scientist Urges Withdrawal Of His Own 'Breakthrough' Stem Cell Research
 Cardiac Stem Cell Therapy And The Promise Of Heart Regeneration
 America Makes Funding Contract Enables Pitt Researchers To Explore 3-D-Printed Bone And Tissue Scaffolds
 Healios And Dainippon Sumitomo Pharma Establish A Joint Venture Company For Regenerative Medicine And Cell Therapy Business
 Neostem And Mass. Eye And Ear/Schepens Eye Research Institute Announce Second Research Collaboration Exploring Neostemхs Vselє Technology For Retinal Repair
 Dendreon Announces Plans To Make Provenge Commercially Available In Europe
 Admedus Obtains Fda Approval For Cardiocel
 Cinven Invests In Medpace, Citing Strong Growth Drivers In The Cro Market
 Regenx Biosciences And Esteve Enter Into License Agreement For Rare Lysosomal Storage Disorder
 Plasticell Signs Deal With Jcr Pharmaceuticals To Use Combicult Stem Cell Technology In Japan
 Cell Therapy Catapult & University Of Leeds To Collaborate On Acellular Scaffolds
 Scientists Develop Stem Cell Based Method For Restoring Strength To Damaged Skeletal Muscles In Elderly
 Parcell Laboratories Partners With The University Of Pittsburgh Medical Center To Study Effective Stem Cell-Based Wrinkle Treatments
 Prima Biomed And Neopharm Group Execute Final Agreement For Cvac License Prima Biomed Und Die Neopharm Group Schlie?En Finale Vereinbarung ?Ber Cvac-Lizenz
 Key European Patent Granted For Use Of Mesoblast's Mesenchymal Precursor Cells In Cardiac And Vascular Conditions
 Pluristem Receives Key 3d Cell Expansion Patent In Australia
 Genea Biocells Becomes The Worldхs Largest Provider Of Human Embryonic Stem Cells
 Cynata Therapeutics Signs Stem Cell Agreement With Waisman Biomanufacturing
 Uniqure Announces Closing Of Initial Public Offering
 California Stem Cell Partners On Cirm Grant To Develop Transplantable 3d Retinas
 Riken, Kyoto University To Partner In Stap Cell Applications
 Brainstorm Receives Us Notice Of Allowance For Its Key Stem Cell Technology Patent
 Mesoblast's Mpcs Shown To Alleviate Back Pain In Phase Ii Trial
 Regeneus To Collaborate With Lonza For Us Cryoshot Trial
 Brainstorm Signs Definitive Agreement With Mayo Clinic For Als Clinical Trial And Nurown Manufacturing
 Kiadis Pharma Initiates Collaboration For Personalized Immunotherapies Using Atirє With Technische Universit?T M?Nchen Within Munich Biotech Cluster
 Medigene Acquires Trianta Immunotherapies
 Tigenix To Sell Dutch Manufacturing Facility To Pharmacell
 Pharmacell To Purchase Cell Therapy Production Facility From Tigenix
 News Release: Regeneus Partners With Lonza For Manufacturing Cryoshot Canine Cell Therapy Product For Us Fda Trial
 Organogenesis Inc. Announces Acquisition Of Dermagraft From Shire
 Derma Sciences Enters The Skin Substitute Market With Licensing Agreement For Innovative Amniotic Membrane Wound Care Products
 Organovo Announces Collaboration With National Institutes Of Health
 Athersys Announces New Patents In Japan For Stem Cell And Regenerative Medicine Technology
 Biogen Idec And Sangamo Biosciences Announce Global Collaboration To Develop Treatments For Hemoglobinopathies
 Cellular Dynamics Signs Agreement With Nestle Institute Of Health Sciences To Supply Icell(R) And Mycell(R) Products For Nutritional Research
 Immunocore And Medimmune Enter Immunotherapy Agreement To Develop Novel Cancer Therapies
 Thermogenesis Signs Direct Supply Agreement With Cord Blood Registry
 Pluristem Receives Key Placental Cell Therapy Patent In Australia
 Baylor College Of Medicine, Chi St. Lukeхs Health, Texas Heart Institute Collaboration: Executive Biographies
 Capricor Therapeutics And Janssen Biotech, Inc. Enter Into Collaboration Agreement And Exclusive License Option
 Thermo Fisher Scientific Reaches Agreement To Sell Its Cell Culture, Gene Modulation And Magnetic Beads Businesses To Ge Healthcare
 Pall Corp. Signs Agreement To Acquire Atmiхs Lifesciences Business
 Intrexon To Acquire Medistem To Generate Multipotent Cells
 America Stem Cell, Inc. Changes Its Name To Targazyme, Inc.
 Novartis Needs Special Delivery For Potent Cell Therapy
 Regenerative Medicine: Mayo Clinic And Collaborators Develop New Tool For Transplanting Stem Cells
 Regenx And Lysogene Enter Into License Agreement For Treatment Of Mps Iiia Using Raavrh10 Vectors
 Jain Foundation Signs Agreement With Cellular Dynamics To Create Ipsc Lines From Patients With Muscular Dystrophies
 Nyscf And Personalgenomes.Org In Groundbreaking Collaboration Combine Genomic Sequencing And Stem Cell Technology To Understand Human Disease 
 Singapore Scientists Make Breakthrough In Regenerative Medicine 
 Astrazeneca, Lieber Institute Join To Develop Neuroscience Therapeutics 
 Txcell Obtains Manufacturing Accreditation Status For Its French Cell Therapy Manufacturing Facility 
 Living Cell Obtains Approval To Continue Parkinson's Trial
 Aussie Stem Cell Firms Switch To Japanese Fast Lanes
 Mesoblastхs Mpcs Enhance Cardiac Function
 Mesoblastхs Partner Allowed To Conduct Phase Iii Heart Trial
 Scientists Create Artificial Skin From Stem Cells Of Umbilical Cord 
 Molmed Enters An Agreement With Gsk For The Manufacture Of The Experimental Gene Therapy For Compassionate Use For Ada-Scid
 Q Therapeutics Receives Orphan Drug Designation From U.S. Food & Drug Administration For Q-Cells For Treatment Of Als
 American Cryostem And Protein Genomics Form Autogenesis Corporation To Support Development Of Unique Stem Cell-Based Wound Products
 Terumo Bct Releases Software 2 For Quantum Cell Expansion System
 Ge Healthcare Life Sciences Launches Xuriє Technology Family For Cell Therapy Manufacturing 
 Neostem Subsidiary Progenitor Cell Therapy Announces Cell Therapy Manufacturing Collaboration With Atmi 
 Merck Serono, Kadimastem Collaborate On Cell-Based Drug Screening 
 Stem Cells For Regeneus
 Fidelity Biosciences And Regenx Biosciences Launch Dimension Therapeutics To Develop And Commercialize Novel Aav Gene Therapy Products
 Stemcells, Inc. Acquires Seminal Neural Stem Cell Patent Portfolio
 Mesoblast Updates Market On Registration Plans For Gvhd Cell Product In Japan 
 Mesoblast Acquires Osirisх Culture Expanded Stem Cell Therapeutic Business 
 Tap Biosystems Group Plc Announces Acquisition Offer By Sartorius Stedim Biotech 
 Asterias Biotherapeutics, Inc., A Subsidiary Of Biotime, Inc., Acquires Geronхs Embryonic Stem Cell Assets 
 Mesoblast To Acquire Stem Cell Business From Osiris
 First Parkinson's Patient Implanted With Lct's Ntcell
 Efficacy Of Allied's Cardiocel Proven In A Long-Term Test.
 Bioheart Announces Agreement With Invitrx To License Adipose Derived Stem Cells
 Biotime Signs Exclusive Agreement With Jade Therapeutics For Ophthalmic Drug Delivery Applications Of Hystem Technology
 Reinnervate Ltd And Roslin Cellab To Partner Around 3d Stem Cell Printing Products And Technologies
 Harvard's Wyss Institute And Charit?, One Of Europe's Largest University Hospitals, Announce Partnership
 Evotec And Harvard Stem Cell Institute Form Curemn Collaboration To Advance Als Research 
 Cell Therapy Catapult & Roslin Cells To Create Clinical Grade Stem Cells To Accelerate Research Into New Treatments
 Sernova And Medicyte To Collaborate On Cell-Based Therapy To Treat Haemophilia 
 Novartis Announces An Exclusive Global Licensing And Research Collaboration With Regenerex, Leveraging A Novel Cell Platform To Broaden Presence In The Cell Therapy Space 
 Llied Healthcare Secures Important Ce Mark For Cardiocel
 Avita Enlists First Three Patients For Recell Spray On Skin Trial
 Avita Medical Announces Completion Of Enrollment In Recell Trial For Vitiligo
 Sangamo Biosciences To Acquire Ceregene
 Fda Approves Msc-Np Therapy As Investigational New Drug In Ms Clinical Trial: A Research Milestone
 Vital Therapies, Inc. Receives Orphan Designation In Europe 
 Doors Open For Australian Biotech Companies In Switzerland
 Regenx Biosciences And Audentes Therapeutics Enter Into Exclusive License Agreement For Development Of Treatments For Serious, Rare Muscle Diseases Using Navtm Vectors
 Stemcells, Inc. Launches Alzheimer's Disease Program Supported By California Institute For Regenerative Medicine
 Brainstormхs Nurown Cell Therapy Receives Orphan Drug Designation In The European Union For Als 
 Biotech Firmхs Stem-Cell Deal Could Reap Rewards In China 
 Transatlantic Partnership To Tackle Neurodegenerative Disease 
 Thermogenesis And Totipotentrx Announce Definitive Merger Agreement 
 Neostem Advances Autoimmune Platform Through Ucsf Collaboration 
 Sernova Receives Patent Allowance For Therapeutic Immune Privileged Cell Technologies
 Capricor And Nile Therapeutics Announce Merger Agreement 
 Pluristemхs South Korean Partner Files Ind With Korean Fda For Plx Cells 
 Mesoblast Wins Japanese Patent For Stem Cell Platform
 Life Technologies Expands Range Of Stem Cell Reprogramming Solutions 
 Emd Millipore Launches Pluristemє Human Es/Ips Medium For The Expansion Of Human Embryonic And Induced Pluripotent Stem Cells 
 Cti Clinical Trial And Consulting Services Announces Acquisition Of S2 Statistical Solutions 
 Our Lady Of Lourdes Medical Center & The Heart House Participating In Research Study Using Adult Stem Cells For Chronic Cardiac Condition
 Stem Cells Reach Standard For Use In Drug Development 
 Mesoblastхs Preclinical Trial Results Of Intracoronary Cell Therapy Published In Circulation Research 
 American Cryostem To Collaborate With Rutgers University On Adipose-Derived Stem Cell Research
 A*Starхs Genome Institute Of Singapore Partners Oxford Biodynamics To Discover And Monitor Cells For Pathologies Or Abnormalities
 Pluristem Develops Plx-Rad Cells For Use In Hematology 
 Vistagen Therapeutics And Duke University Publish Results On Production Of Functional 3d Human Heart Tissue 
 Miltenyi Biotec Acquires Owl Biomedical, Inc. 
 American Cryostem Marks Major Global Expansion Milestone: Receives First International Shipment Of Adipose Tissue For Processing And Cryo-Storage From Hong Kong
 Tigenix Reports Positive Phase Iia Study Results In Refractory Rheumatoid Arthritis With Allogeneic Stem Cell Product Cx611
 Biotime Enters Into Worldwide License Agreement With Ucla To Develop Therapy For The Treatment Of Stroke
 Stem Cell Therapeutics Licenses Exclusive Rights To Clinical Cancer Stem Cell Program 
 Neuralstem Receives Fda Approval To Commence Phase Ii Stem Cell Trial In Amytrophic Lateral Sclerosis
 Leading The Way In Regenerative Medicine
 Thermo Fisher Scientific To Acquire Life Technologies Corporation 
 Vistagen Announces $36 Million Strategic Financing Agreement 
 Brainstorm Partners With Dana-Farber For Nurownє Production In Phase Ii Als Clinical Trial
 Maryland Invests $500,000 In Gaithersburg Medicine Company 
 Bioheart Completes Fda Registration For Tissue Bank Establishment 
 Elastic Patch Supports Cardiac Cell Growth
 Reneuron And Cell Therapy Catapult In Landmark Collaboration On New Cell Manufacturing Technologies - First Uk Corporate Deal For Ct Catapult To Focus On Reneuronхs Lead Cell Therapy Candidate 
 Bluebird Bio Announces Global Strategic Collaboration With Celgene To Advance Gene Therapy In Oncology 
 Cryo-Cell International Affiliate Earns Patent For Processing Umbilical Cord Blood For Therapeutic Use In Treating Neurodegenerative Diseases And Spinal Cord And Brain Injuries 
 Sistemic And Pct Initiate Study On Novel Stem Cell Characterization Technology 
 Stem Cell Company Athersys Expects More R&D Spending, Potential Partnerships In 2013 
 Histogen Creates Pur Biologics, A Joint Venture Developing Next-Generation, Biologic Solutions In Orthopedic Applications 
 U Of M Researchers Utilize Genetically Corrected Stem Cells To Spark Muscle Regeneration 
 Roche And Biolamina Start Collaboration To Develop Novel Cell Culture Systems 
 Life Technologies Signs License And Collaborative Stem Cell Research Agreement With Harvard University
 Vistagen Therapeutics Enters Strategic Collaboration With Celsis To Further Advance Liversafe 3dє 
 Riken To Apply For Approval To Conduct Ips Clinical Research 
 Sernova And Centre For Commercialization Of Regenerative Medicine Partner To Treat Chronic Diseases 
 Modeling Alzheimer's Disease Using Ipscs Reveals Stress Phenotypes Associated With Intracellular A? And Differential Drug Responsiveness
 An Open Label Dose Escalation Study To Evaluate The Safety Of Administration Of Non-Viral Sdf-1 Plasmid To Treat Symptomatic Ischemic Heart Failure 
 Organovo Partners With Zenbio To Create 3d Tissue Models 
 Allied Receives Iso Certification For Cardiocel
 Mesoblast Up Following Patents In Us And China
 Allied Finds Cardiocel Better At Seeding Stem Cells
 Cynataхs Stem Cells Could Potentially Treat Critical Limb Ischemia
 Allied Healthcare Researches New Tissue Engineering Applications
 Organovo And Ohsu Knight Cancer Institute Announce Collaboration In Cancer Research 
 Monitoring And Robust Induction Of Nephrogenic Intermediate Mesoderm From Human Pluripotent Stem Cells 
 Cellular Dynamics Announces The Production Of Human Ipsc Lines Under Cgmp Conditions 
 Neostem's Subsidiary, Progenitor Cell Therapy, Enters Into A Cell Therapy Manufacturing Services Agreement With Adaptimmune
 New Collaboration Between Ccrm And Nikon To Reap Benefits Outside The Lab 
 Sanbio Announces Enrollment Of The Second Cohort Of Patients In Its Clinical Trial Of Stem Cell Therapy For Chronic Stroke
 Neuralstem Receives Fda Approval To Commence Spinal Cord Injury Trial
 Allied Healthcare Explores New Tissue Engineering Applications 
 Texas Heart Institute Selected To Store Cells Used In Nationwide Research
 Athersys Announces New Patents In Japan For Stem Cell And Regenerative Medicine Technology
 Brainstorm Achieves Important New Development For Commercialization Of Nurown
 Xthermo Fisher Scientific Expands Cryopreservation Reagents For Cell Culture
 Canadian Firm Aims To Treat Diabetes Naturally With A Cell Therapy/Device Combination
 Industry Leaders Predict A Great Year For Regenerative Medicine 
 Brainstorm Receives Notice Of Allowance To Grant European Patent Covering Its Stem Cells For The Treatment Of Cns Diseases 
 Advanced Cell Technology Achieves Clinical Milestone
 Geron Sells Stem Cell Assets
 Progenitor Cell Therapy, And Hackensack University Medical Center Enter Into A Cell Processing And Storage Services Agreement 
 New Company Applies Regenerative Medicine To Corneal Transplantation 
 Biotime Signs Definitive Agreement With Geron Regarding Stem Cell Assets 
 Cellular Dynamics Announces Agreement With Astrazeneca On Use Of Ipsc-Derived Human Cells In Drug Discovery Research
 Sanford-Burnham And Intrexon Corporation Establish Collaboration To Accelerate Stem Cell Research
 
 E. Key Company Profiles
 The Americas
 Europe
 Asia-Pacific
 Rest Of World
 
 Iv. Industry Company Database
 
 V. Appendix
 Research Focus
 Data Analysis
 Currency Exchange Rates
 About Axis Research Mind
 Disclaimer
 Feedback

List Of Tables

I. Report Focus
1. Regenerative Medicine Therapeutics Companies Breakdown - %
2. Regenerative Medicine Cell & Tissue Banks Breakdown - %
3. Tissue Engineering Products Currently Available In The Market For Following Areas
4. Economic Impact Of Various Diseases (In $Usd Billion)
5. Marketed Cell Therapies By Jurisdiction For Usa, Europe, South Korea, Japan, Israel, Canada & New Zealand
6. Leading Commercial Cell Therapy Products Of Key Companies
7. Cell Therapy Trials By Therapeutic Area For Early To Mid-Stage (Phase 1, 1/2, 2) - % Breakdown
8. List Of Therapeutic Areas Identified, Vectors Used And Gene Types Transferred In Gene Therapy Clinical Trials
9. Usa Annual Healthcare Cost Per Capita By Age (In $Usd)
10. Healthcare Expenses In 2009 By Expense Category (From Health U.S.A, 2011)

Ii. Regenerative Medicine - Market Briefing

The Americas
11. Regenerative Medicine - Therapeutic Area Market - Orthopedics, Skin/Integumentary, Cardiology, Neurology, Urology And Other For The Americas Current Trends, Estimates & Forecasts - (2013-2019, In Usd$ Million)
12. Regenerative Medicine - Therapeutic Area - Orthopedics, Skin/Integumentary, Cardiology, Neurology, Urology And Other - % Of The Americas Market Value - (2016-2019)

Europe
13. Regenerative Medicine - Therapeutic Area Market - Orthopedics, Skin/Integumentary, Cardiology, Neurology, Urology And Other For Europe Current Trends, Estimates & Forecasts - (2013-2019, In Usd$ Million)
14. Regenerative Medicine - Therapeutic Area - Orthopedics, Skin/Integumentary, Cardiology, Neurology, Urology And Other - % Of European Market Value - (2016-2019)

Asia-Pacific
15. Regenerative Medicine - Therapeutic Area Market - Orthopedics, Skin/Integumentary, Cardiology, Neurology, Urology And Other For Asia-Pacific Current Trends, Estimates & Forecasts - (2013-2019, In Usd$ Million)
16. Regenerative Medicine - Therapeutic Area - Orthopedics, Skin/Integumentary, Cardiology, Neurology, Urology And Other - % Of Asia-Pacific Market Value - (2016-2019)

Rest Of World
17. Regenerative Medicine - Therapeutic Area Market - Orthopedics, Skin/Integumentary, Cardiology, Neurology, Urology And Other For Rest Of World Current Trends, Estimates & Forecasts - (2013-2019, In Usd$ Million)
18. Regenerative Medicine - Therapeutic Area - Orthopedics, Skin/Integumentary, Cardiology, Neurology, Urology And Other - % Of Rest Of World Market Value - (2016-2019)

Ii. Market Analysis
19. Global Regenerative Medicine - Segmentation By Therapeutic Areas

Regenerative Medicine Р Global
20. Regenerative Medicine Market - Global Current Trends, Estimates & Forecasts - (2013-2019, In Usd$ Million)
21. Regenerative Medicine - Geographic Region Current Trends, Estimates & Forecasts For The Americas, Europe, Asia-Pacific And Rest Of World - (2013-2019, In Usd$ Million)
22. Regenerative Medicine - % Of The Americas, Europe, Asia-Pacific And Rest Of World Market Value - (2016-2019)

Regenerative Medicine - By Geography
The Americas
23. Regenerative Medicine - Usa, Canada, Brazil And Rest Of The Americas - (2013-2019, In Usd$ Million)
24. Regenerative Medicine - % Of Usa, Canada, Brazil And Rest Of The Americas Market Value - (2016-2019)

Europe
25. Regenerative Medicine - Germany, United Kingdom, France, Switzerland, Spain, The Netherlands, Russia And Rest Of Europe - (2013-2019, In Usd$ Million)
26. Regenerative Medicine - % Of Germany, United Kingdom, France, Switzerland, Spain, The Netherlands, Russia And Rest Of Europe Market Value - (2016-2019)

Asia-Pacific
27. Regenerative Medicine - Japan, South Korea, Australia, China, India And Rest Of Asia-Pacific - (2013-2019, In Usd$ Million)
28. Regenerative Medicine - % Of Japan, South Korea, Australia, China, India And Rest Of Asia-Pacific Market Value - (2016-2019)

Rest Of World
29. Regenerative Medicine - Africa And Middle East - (2013-2019, In Usd$ Million)
30. Regenerative Medicine - % Of Africa And Middle East Market Value - (2016-2019)

Regenerative Medicine - By Therapeutic Area
31. Regenerative Medicine - Therapeutic Area Market - Orthopedics, Skin/Integumentary, Cardiology, Neurology, Urology And Other For Global Current Trends, Estimates & Forecasts - (2013-2019, In Usd$ Million)
32. Regenerative Medicine - Therapeutic Area - Orthopedics, Skin/Integumentary, Cardiology, Neurology, Urology And Other - % Of Global Market Value - (2016-2019)

Regenerative Medicine - Therapeutic Area - By Geography
Orthopedics
33. Orthopedics Market - Geographic Region Current Trends, Estimates & Forecasts For The Americas, Europe, Asia-Pacific And Rest Of World - (2013-2019, In Usd$ Million)
34. Orthopedics - % Of The Americas, Europe, Asia-Pacific And Rest Of World Market Value - (2016-2019)

The Americas
35. Orthopedics Market - Usa, Canada, Brazil And Rest Of The Americas - (2013-2019, In Usd$ Million)
36. Orthopedics - % Of Usa, Canada, Brazil And Rest Of The Americas Market Value - (2016-2019)

Europe
37. Orthopedics Market - Germany, United Kingdom, France, Switzerland, Spain, The Netherlands, Russia And Rest Of Europe - (2013-2019, In Usd$ Million)
38. Orthopedics - % Of Germany, United Kingdom, France, Switzerland, Spain, The Netherlands, Russia And Rest Of Europe Market Value - (2016-2019)

Asia-Pacific
39. Orthopedics Market - Japan, South Korea, Australia, China, India And Rest Of Asia-Pacific - (2013-2019, In Usd$ Million)
40. Orthopedics - % Of Japan, South Korea, Australia, China, India And Rest Of Asia-Pacific Market Value - (2016-2019)

Rest Of World
41. Orthopedics Market - Africa And Middle East - (2013-2019, In Usd$ Million)
42. Orthopedics - % Of Africa And Middle East Market Value - (2016-2019)

Skin/Integumentary
43. Skin/Integumentary Market - Geographic Region Current Trends, Estimates & Forecasts For The Americas, Europe, Asia-Pacific And Rest Of World - (2013-2019, In Usd$ Million)
44. Skin/Integumentary - % Of The Americas, Europe, Asia-Pacific And Rest Of World Market Value - (2016-2019)

The Americas
45. Skin/Integumentary Market - Usa, Canada, Brazil And Rest Of The Americas - (2013-2019, In Usd$ Million)
46. Skin/Integumentary - % Of Usa, Canada, Brazil And Rest Of The Americas Market Value - (2016-2019)

Europe
47. Skin/Integumentary Market - Germany, United Kingdom, France, Switzerland, Spain, The Netherlands, Russia And Rest Of Europe - (2013-2019, In Usd$ Million)
48. Skin/Integumentary - % Of Germany, United Kingdom, France, Switzerland, Spain, The Netherlands, Russia And Rest Of Europe Market Value - (2016-2019)

Asia-Pacific
49. Skin/Integumentary Market - Japan, South Korea, Australia, China, India And Rest Of Asia-Pacific - (2013-2019, In Usd$ Million)
50. Skin/Integumentary - % Of Japan, South Korea, Australia, China, India And Rest Of Asia-Pacific Market Value - (2016-2019)

Rest Of World
51. Skin/Integumentary Market - Africa And Middle East - (2013-2019, In Usd$ Million)
52. Skin/Integumentary - % Of Africa And Middle East Market Value - (2016-2019)

Cardiology
53. Cardiology Market - Geographic Region Current Trends, Estimates & Forecasts For The Americas, Europe, Asia-Pacific And Rest Of World - (2013-2019, In Usd$ Million)
54. Cardiology - % Of The Americas, Europe, Asia-Pacific And Rest Of World Market Value - (2016-2019)

The Americas
55. Cardiology Market - Usa, Canada, Brazil And Rest Of The Americas - (2013-2019, In Usd$ Million)
56. Cardiology - % Of Usa, Canada, Brazil And Rest Of The Americas Market Value - (2016-2019)

Europe
57. Cardiology Market - Germany, United Kingdom, France, Switzerland, Spain, The Netherlands, Russia And Rest Of Europe - (2013-2019, In Usd$ Million)
58. Cardiology - % Of Germany, United Kingdom, France, Switzerland, Spain, The Netherlands, Russia And Rest Of Europe Market Value - (2016-2019)

Asia-Pacific
59. Cardiology Market - Japan, South Korea, Australia, China, India And Rest Of Asia-Pacific - (2013-2019, In Usd$ Million)
60. Cardiology - % Of Japan, South Korea, Australia, China, India And Rest Of Asia-Pacific Market Value - (2016-2019)

Rest Of World
61. Cardiology Market - Africa And Middle East - (2013-2019, In Usd$ Million)
62. Cardiology - % Of Africa And Middle East Market Value - (2016-2019)

Neurology
63. Neurology Market - Geographic Region Current Trends, Estimates & Forecasts For The Americas, Europe, Asia-Pacific And Rest Of World - (2013-2019, In Usd$ Million)
64. Neurology - % Of The Americas, Europe, Asia-Pacific And Rest Of World Market Value - (2016-2019)

The Americas
65. Neurology Market - Usa, Canada, Brazil And Rest Of The Americas - (2013-2019, In Usd$ Million)
66. Neurology - % Of Usa, Canada, Brazil And Rest Of The Americas Market Value - (2016-2019)

Europe
67. Neurology Market - Germany, United Kingdom, France, Switzerland, Spain, The Netherlands, Russia And Rest Of Europe - (2013-2019, In Usd$ Million)
68. Neurology - % Of Germany, United Kingdom, France, Switzerland, Spain, The Netherlands, Russia And Rest Of Europe Market Value - (2016-2019)

Asia-Pacific
69. Neurology Market - Japan, South Korea, Australia, China, India And Rest Of Asia-Pacific - (2013-2019, In Usd$ Million)
70. Neurology - % Of Japan, South Korea, Australia, China, India And Rest Of Asia-Pacific Market Value - (2016-2019)

Rest Of World
71. Neurology Market - Africa And Middle East - (2013-2019, In Usd$ Million)
72. Neurology - % Of Africa And Middle East Market Value - (2016-2019)

Urology
73. Urology Market - Geographic Region Current Trends, Estimates & Forecasts For The Americas, Europe, Asia-Pacific And Rest Of World - (2013-2019, In Usd$ Million)
74. Urology - % Of The Americas, Europe, Asia-Pacific And Rest Of World Market Value - (2016-2019)

The Americas
75. Urology Market - Usa, Canada, Brazil And Rest Of The Americas - (2013-2019, In Usd$ Million)
76. Urology - % Of Usa, Canada, Brazil And Rest Of The Americas Market Value - (2016-2019)

Europe
77. Urology Market - Germany, United Kingdom, France, Switzerland, Spain, The Netherlands, Russia And Rest Of Europe - (2013-2019, In Usd$ Million)
78. Urology - % Of Germany, United Kingdom, France, Switzerland, Spain, The Netherlands, Russia And Rest Of Europe Market Value - (2016-2019)

Asia-Pacific
79. Urology Market - Japan, South Korea, Australia, China, India And Rest Of Asia-Pacific - (2013-2019, In Usd$ Million)
80. Urology - % Of Japan, South Korea, Australia, China, India And Rest Of Asia-Pacific Market Value - (2016-2019)

Rest Of World
81. Urology Market - Africa And Middle East - (2013-2019, In Usd$ Million)
82. Urology - % Of Africa And Middle East Market Value - (2016-2019)

Other Therapeutic Areas (Regenerative Medicine)
83. Other Therapeutic Areas (Regenerative Medicine) Market - Geographic Region Current Trends, Estimates & Forecasts For The Americas, Europe, Asia-Pacific And Rest Of World - (2013-2019, In Usd$ Million)
84. Other Therapeutic Areas (Regenerative Medicine) - % Of The Americas, Europe, Asia-Pacific And Rest Of World Market Value - (2016-2019)

The Americas
85. Other Therapeutic Areas (Regenerative Medicine) Market - Usa, Canada, Brazil And Rest Of The Americas - (2013-2019, In Usd$ Million)
86. Other Therapeutic Areas (Regenerative Medicine) - % Of Usa, Canada, Brazil And Rest Of The Americas Market Value - (2016-2019)

Europe
87. Other Therapeutic Areas (Regenerative Medicine) Market - Germany, United Kingdom, France, Switzerland, Spain, The Netherlands, Russia And Rest Of Europe - (2013-2019, In Usd$ Million)
88. Other Therapeutic Areas (Regenerative Medicine) - % Of Germany, United Kingdom, France, Switzerland, Spain, The Netherlands, Russia And Rest Of Europe Market Value - (2016-2019)

Asia-Pacific
89. Other Therapeutic Areas (Regenerative Medicine) Market - Japan, South Korea, Australia, China, India And Rest Of Asia-Pacific - (2013-2019, In Usd$ Million)
90. Other Therapeutic Areas (Regenerative Medicine) - % Of Japan, South Korea, Australia, China, India And Rest Of Asia-Pacific Market Value - (2016-2019)

Rest Of World
91. Other Therapeutic Areas (Regenerative Medicine) Market - Africa And Middle East - (2013-2019, In Usd$ Million)
92. Other Therapeutic Areas (Regenerative Medicine) - % Of Africa And Middle East Market Value - (2016-2019)

Regenerative Medicine - Biological Substitutes - By Type
93. Regenerative Medicine - Biological Substitutes Market - Cells And -Biomaterials, Biomolecules, Manufacturing Factors And Other For Global Current Trends, Estimates & Forecasts - (2013-2019, In Usd$ Million)
94. Regenerative Medicine - Biological Substitutes - Cells And Biomaterials, Biomolecules, Manufacturing Factors And Other - % Of Global Market Value - (2016-2019)

B. Growth Rate Analysis
95. Regenerative Medicine Market - Geographic Region - % Growth Rate Forecasts - (2013-2019)
96. Regenerative Medicine - By Therapeutic Area - % Growth Rate Forecasts For Orthopedics, Skin/Integumentary, Cardiology, Neurology, Urology And Other - (2013-2019)

C. Investment Focus
97. Regenerative Medicine - Forecasted Cagr% - 2013-2019 - Top 8 Countries - Usa, Brazil, Spain, Russia, China, Japan, South Korea And India
98. Regenerative Medicine - Therapeutic Area - Orthopedics, Skin/Integumentary, Cardiology, Neurology, Urology And Other - Forecasted Cagr% - Value - 2012-2018 - Top 8 Countries - Usa, Japan, China, France, India, South Korea, Russia And Brazil

Iii. Industry Overview
99. Worldwide Key Players Into Regenerative Medicine Industry That Project Improved Market Activities In The Near Future
Key Company Profiles

The Americas

Cell2b (Usa)
Angiocrine Bioscience (Usa)
Platelet Biogenesis (Usa)
Biomatrica, Inc (Usa)
Athersys, Inc. (Usa)
Cellular Dynamics International, Inc. (Usa)
Tengion Inc (Usa)
Vericel Corporation (Usa)
Wright Medical Technology (Usa)
Tissuegene, Inc. (Usa)
Shire Regenerative Medicine (Usa)
Regen Biopharma (Bio-Matrix Scientific Group) (Usa)
Dsm Biomedical (Usa)
Harvard Apparatus Regenerative Technology (Usa)

Europe

Cellserve Gmbh (Germany)
Trakcel Ltd (United Kingdom)
Crispr Therapeutics (Switzerland)

Asia-Pacific

Cytori Therapeutics Inc (Japan)
Cyfuse Biomedical Kk (Japan)
Regenovo Biotechnology (China)
Cynata Therapeutics Limited (Australia) 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy